241 related articles for article (PubMed ID: 30558966)
21. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.
Osamor JO; Oluwasola AO; Adewole IF
J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470
[TBL] [Abstract][Full Text] [Related]
22. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
[TBL] [Abstract][Full Text] [Related]
23. Morphological, immunohistochemical and chromosome in situ hybridization in the differential diagnosis of Hydatidiform Mole and Hydropic Abortion.
Maggiori MS; Peres LC
Eur J Obstet Gynecol Reprod Biol; 2007 Dec; 135(2):170-6. PubMed ID: 17602823
[TBL] [Abstract][Full Text] [Related]
24. p53 expression in placentas with hydropic change and hydatidiform moles.
Cheville JC; Robinson RA; Benda JA
Mod Pathol; 1996 Apr; 9(4):392-6. PubMed ID: 8729978
[TBL] [Abstract][Full Text] [Related]
25. [Roles of p57KIP2 immunohistochemistry and flow cytometry in diagnosis of molar pregnancy].
Yang SM; You JF; Zhang XW; Zheng J; Liao SL
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):580-4. PubMed ID: 20079184
[TBL] [Abstract][Full Text] [Related]
26. Immunoreactivity of p53, Mdm2, p21(WAF1/CIP1) Bcl-2, and Bax in soft tissue sarcomas: correlation with histologic grade.
Sabah M; Cummins R; Leader M; Kay E
Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):64-9. PubMed ID: 17536310
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of P63 in differentiating normal gestation from molar pregnancy.
Heidarpour M; Khanahmadi M
J Res Med Sci; 2013 Jun; 18(6):462-6. PubMed ID: 24250692
[TBL] [Abstract][Full Text] [Related]
28. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
[TBL] [Abstract][Full Text] [Related]
29. p53 and Bcl-2 oncoprotein expression in placentas with hydropic changes and partial and complete moles.
Al-Bozom IA
APMIS; 2000 Nov; 108(11):756-60. PubMed ID: 11211969
[TBL] [Abstract][Full Text] [Related]
30. Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression.
Baretton GB; Klenk U; Diebold J; Schmeller N; Löhrs U
Br J Cancer; 1999 May; 80(3-4):546-55. PubMed ID: 10408865
[TBL] [Abstract][Full Text] [Related]
31. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles.
Jun SY; Ro JY; Kim KR
Histopathology; 2003 Jul; 43(1):17-25. PubMed ID: 12823708
[TBL] [Abstract][Full Text] [Related]
32. p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.
Fulop V; Mok SC; Genest DR; Gati I; Doszpod J; Berkowitz RS
J Reprod Med; 1998 Feb; 43(2):119-27. PubMed ID: 9513873
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the role of histopathology and DNA image analysis in the diagnosis of molar and non-molar abortion: a study of 89 cases in the center of Tunisia.
Landolsi H; Missaoui N; Yacoubi MT; Trabelsi A; Rammeh-Rommani S; Hidar S; Gribaa M; Hmissa S; Mokni M
Pathol Res Pract; 2009; 205(11):789-96. PubMed ID: 19665315
[TBL] [Abstract][Full Text] [Related]
34. Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis.
Liu XP; Tsushimi K; Tsushimi M; Kawauchi S; Oga A; Furuya T; Sasaki K
Cancer Lett; 2001 Sep; 170(2):183-9. PubMed ID: 11463497
[TBL] [Abstract][Full Text] [Related]
35. Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta.
Petignat P; Laurini R; Goffin F; Bruchim I; Bischof P
Int J Gynecol Cancer; 2006; 16(4):1679-84. PubMed ID: 16884384
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21(WAF1/CIP1) predicts survival and good response to platinin-based chemotherapy.
Costa MJ; Hansen CL; Walls JE; Scudder SA
Hum Pathol; 1999 Jun; 30(6):640-7. PubMed ID: 10374771
[TBL] [Abstract][Full Text] [Related]
37. Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma.
Candelier JJ; Frappart L; Yadaden T; Poaty H; Picard JY; Prévot S; Coullin P
Pathol Oncol Res; 2013 Apr; 19(2):217-27. PubMed ID: 23065465
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Ki-67 (MIB-1) in placentas with hydropic change and partial and complete hydatidiform mole.
Cheville JC; Robinson R; Benda JA
Pediatr Pathol Lab Med; 1996; 16(1):41-50. PubMed ID: 8963630
[TBL] [Abstract][Full Text] [Related]
39. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.
McConnell TG; Murphy KM; Hafez M; Vang R; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):805-17. PubMed ID: 19145201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
